Product code CEE— Clinical Chemistry
125 I-T3 UPTAKE REAGENT
- Classification name
- Radioimmunoassay, Thyroxine-Binding Globulin
- Device class
- Class 2
- Regulation
- 21 CFR 862.1685
- Advisory panel
- Clinical Chemistry
- Total cleared
- 25
- First cleared
- Most recent
Market context for product code CEE
FDA has cleared devices under product code CEE between 1976 and 1995, filed by 20 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.
Clearances per year
last 15 years- 1995
- 1993
- 1991
- 1990
- 1989
- 1988
- 1987
- 1986
- 1984
- 1982
- 1981
- 1980
- 1978
- 1977
- 1976
Top applicants under product code CEE
Recent clearances under product code CEE
- K952284 — AMERLITE TBG ASSAY
- K930010 — ACCESS THYROID UPTAKE ASSAY
- K910677 — IMMULITE(TM) T-UPTAKE
- K905777 — MICROZYME THYROID UPTAKE ENZYME IMMUNOASSAY KIT
- K900240 — DELFIA TBG KIT
- K896991 — ENZYMUN TEST(R) TBK
- K893469 — AMERLITE TBG ASSAY, LAN.0005/1005 240/144 TEST KIT
- K885034 — T-UPTAKE MICROASSAY
- K884201 — FIAGEN TBG TIME-RESOLVED FLUOROIMMUNOASSAY KIT
- K874658 — TECHNICON RA(R) ANALYTE (TBG) (30 C AND 37 C)
- K862109 — ENZYMUN TEST TBG
- K861735 — TIPSEP-TBG ASSAY
- K842167 — TBG RIA
- K842010 — THYROXINE-BINDING GLOBULIN RADIOUMMU
- K841024 — VENTREZYME T4U IMMUNOASSAY T4U
- K822684 — ENDAB THYROID UPTAKE
- K820252 — TBG DIAGNOSTIC KIT
- K810967 — IN-VITRO TBG RADIOIMMUNOASSAY TEST
- K800204 — RIA PHASE TBG
- K781225 — GLOBULIN TEST, HUMAN THYROXINE BINDING
- K780671 — 125 I-T3 UPTAKE REAGENT
- K780486 — STIKSEP-T3 KIT
- K772183 — THYROID BINDING GLOBULIN
- K771341 — SPINSEP-TBG
- K760134 — PROCEDURE, RA, THYROXINE BINDING PROTEIN
Data sourced from openFDA. This site is unofficial and independent of the FDA.